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In aged individuals, increased oxidative damage in cells leads to cellular decline and organ 
dysfunction. Since the mid-1950s, reactive oxygen species (ROS) have been implicated in age-
related organ damage, including hepatic, cardiovascular, and renal disease. While this connection 
has been established for some time, the production and particularly the function of ROS within 
and between cells is still being studied. This review will examine what is known about the 
enzymatic and mitochondrial sources of ROS within cells, and explore their effect on age-related 
diseases in the liver, heart, and kidneys. Fibrosis and functional decline of each of these organs 
has been reported in animal models and clinical data. ROS including hydroxyl radicals (OH
.
), 
hydrogen peroxide (H2O2), and superoxide anion (O2-) are discussed as well as processes that 
produce them: P450 enzymes, xanthine oxidase, NADP oxidase, and the electron transport chain 
(ETC). While ROS are useful for cell signaling, accumulation of these species at high levels is 
damaging. This review will focus on the role of ROS on cell-signaling proteins including NF-κβ, 
TNF-α, and atrial natriuretic factor (ANF), as well as resulting mitochondrial DNA (mtDNA) 
damage. The modulation of these factors by high ROS prevalence, in addition to a decline in 
mtDNA damage repair capabilities over time, is the foundation of age-related oxidative stress. As 
such, implications of reductive enzymes including superoxide dismutase, catalase, and glutathione 
peroxidase are discussed as well. 
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1.0 Introduction to Oxidative Stress 
ROS exist in cells as mediators of inflammation and indicators of damage. Even in young, 
healthy cells, ROS are produced constitutively through mitochondrial ATP production and cell 
metabolism. If oxidative species are present in high concentrations, however, cellular damage 
occurs. In 1956, Harman proposed that lifelong exposure to oxidative damage within the body is 
largely responsible for the aging process [1]. Over time, oxidative species accumulate in nearly 
every tissue, and reduction processes of the body cannot keep up. ROS are problematic in nature 
due to the presence of oxygen atoms with unpaired electrons. Species that commonly accumulate 
in tissues include hydroxyl radicals (OH
.
), superoxide anion (O2-), and hydrogen peroxide (H2O2)
[2]. Scenes of ROS production include the mitochondria, hepatic metabolism, and vascular 
NADH/NADPH oxidase. The macromolecules that become affected by this production include 
carbohydrates, lipids, and DNA. Specifically, mitochondrial DNA is compromised through base 
modulation as well as single and double stranded breaks. In clinical practice, oxidatively modified 
forms of these macromolecules are used as biomarkers for quantifying oxidative stress [3]. This 
ROS production is offset by the enzymatic reduction of these species by molecules called 
antioxidants [4]. It is theorized that the dysregulation of this antioxidant-ROS balance is severely 
compromised by aging [1].  
2 
1.1 Senescence-Associated Secretory Phenotype 
In aged cells, a halting of cellular replication can occur known as senescence. During this 
period, cells exhibit a senescence-associated secretory phenotype (SASP) which, with increased 
ROS production, contributes to cellular damage. Repeated replication of DNA and other cellular 
components leads to mutation and an inclination toward tumorigenesis. The role of this senescence 
is to halt replication in damaged cells to prevent tumor formation [5]. The SASP includes the 
activation of tumor suppressor genes p16 and p53, which upregulate NF-κβ and consequently 
TNF-α expression. Cells exhibiting the SASP are more common with advanced age, and these 
factors become increasingly present in the milieu [6]. In healthy cells, this senescence allows 
tumorigenic or otherwise problematic cells to cease reproduction, protecting organ function. 
Significant levels of ROS are capable of damaging cellular components which, especially in aged 
individuals, leads toward the SASP in a large number of cells. This creates a surplus of senescent 
cells that are releasing transcription factors and cytokines promoting inflammation, degeneration, 
and fibrosis.  
3 
1.2 Production of ROS 
Over the course of the human lifetime, we are exposed to ROS both endogenously and 
exogenously. Exogenous sources include cigarette smoke, pollution, and ionizing radiation. These 
sources of ROS, though important causes of disease, are not as prominent in aging as endogenous 
sources, and will not be discussed here. 
One of the most ubiquitous endogenous ROS is the superoxide radical. The organelle 
mainly implicated in endogenous ROS production is the mitochondria [7]. In the mitochondrial 
ETC, oxygen is reduced to water using cytochrome oxidase (Complex IV) as an intermediate 
reservoir. During the reduction process, electrons from other complexes can leak to oxygen atoms 
Figure 1. Model of mtDNA damage caused by oxidative stress. Increased mitochondrial ROS (mtROS) leads 
to decreased ETC functionality and increased proton leak [2]. 
Figure 2. Summary of the ROS damage process. An increased ROS pool leads to cellular damage, while lower
ROS levels affect cell messengers and machinery [3].Figure 3. Model of mtDNA damage caused by oxidative 
stress. Increased mitochondrial ROS (mtROS) leads to decreased ETC functionality and increased proton leak 
[2].
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which become superoxide radicals. These radicals are increasingly formed after mtDNA becomes 
damaged through long-term exposure to ROS. This process constitutes the basis of the 
mitochondrial free radical theory of aging. ROS are capable of mutating mtDNA, which has less 
efficient proofreading and repair mechanisms than nuclear DNA [8]. The ETC can produce 
superoxide anion through complexes I and III as electrons are being shuttled through to complex 
IV. Additionally, the electron shuttle Cytochrome C is capable of becoming damaged due to ROS
exposure. Cytochrome C damage can result in the uncoupling of this electron carrier from the 
ETC. This allows free electrons to react with nearby macromolecules, like mtDNA [9]. Exposure 
and subsequent mutation by ROS further increases the probability of electron and ROS leak, as 
shown in Figure 1 [10]. f in combination with the close proximity of the ETC to mtDNA, makes 
the mitochondria vulnerable to free radical damage. A source of ROS exists in the use of enzymes 
in tissues as well, including xanthine oxidase, NADPH oxidase, and the cytochrome P450 family 
of enzymes. Xanthine oxidase, an enzyme responsible for purine catabolism, catalyzes the 
breakdown of hypoxanthine into uric acid. Purine metabolism is necessary as cells are recycled, 
or heavy purine meals are digested like seafood, alcohol, or meats. During hypoxanthine 
metabolism, this enzyme produces superoxide radicals which must then be reduced by superoxide 
dismutase [11]. Superoxide radicals are produced by NADPH oxidase as well. NADPH oxidase is 
responsible for innate immunity in fighting oxygen-labile pathogenic organisms [12]. Upon 
recognition of a bacterial invader, NADPH oxidase is capable of producing superoxide anion that 
can cause damage to bacterial macromolecules. The other function of NADPH oxidase is in cell-
cell communication. Release of small amounts of ROS in response to hormones like angiotensin 
allows one cell to communicate environmental cues to its neighbors [13]. ROS production by the 
p450 enzymes occurs through a variety of mechanisms. An increase in ROS production by these 
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enzymes can be caused by the metabolism of xenobiotics like azithromycin, which will further 
contribute to the ROS pool [14]. These biologic processes:  the ETC, xanthine oxidase, NADPH 
oxidase, and P450 are all necessary components of a functioning human organism. Their ROS 
byproducts, however, have consequences over time, causing age-related degeneration of tissues 
and organ systems.  
  
6 
2.0 Aging and ROS 
Humans, like all animals, have a finite life cycle. The start of a functional decline toward 
senescence can be caused by many things; one of which is long term oxidative stress (Figure 2). 
Species with longer lifespans than humans have both greater antioxidant activity and more efficient 
antioxidant systems when compared to human cells [15]. We know, therefore, that oxidative 
species play a part in cellular decline, but how exactly does this happen? As mentioned previously, 
ROS are being produced at almost all times in all cells; man requires molecular oxygen to survive. 
Protons that leak from the ETC are capable of reacting with molecular oxygen used in the 
mitochondria. This combination generates hydroxide radicals which are then further metabolized 
Figure 2. Summary of the ROS damage process. An increased ROS pool leads to cellular damage, while 
lower ROS levels affect cell messengers and machinery [3]. 
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to create hydrogen peroxide. In cells, oxygen and water are metabolized into hydrogen peroxide 
via superoxide dismutase. From there, catalase and glutathione peroxidase eliminate hydrogen 
peroxide with water and oxygen as products, acting as antioxidants. Issues related to oxidative 
stress arise when a surplus of oxidants exists compared to antioxidant levels [16]. These issues are 
often what cause problematic age-related ailments such as liver disease, heart disease, and kidney 
dysfunction.  
8 
3.0 Oxidative Organ Damage 
In the liver, hepatocytes are a major site of metabolism due to extensive expression of the 
cytochrome P450 enzymes, and high perfusion. Here, P450-mediated-metabolism of various 
compounds at the endoplasmic reticulum can produce high levels of reactive H2O2 [17]. These 
heme-containing enzymes are capable of binding and releasing oxygen in the absence of their 
substrate. This release of oxygen has the opportunity to interact with hydrogen and create hydrogen 
peroxide [18]. In an aged liver, the concentration of the catalase and glutathione peroxidase 
enzymes, which break down H2O2, become decreased due to mtDNA damage from life-long ROS 
exposure. This leads to less efficient clearing of the strongly oxidative peroxide molecules from 
hepatocytes [19]. The sustained increase in ROS, and mtDNA damage, can result in the activation 
of transcription factors such as Early Growth Response Protein 1 (Egr-1), Nuclear Factor Kappa β 
(NF-κβ), and Activator Protein 1 (AP-1),  which ultimately trigger hepatic senescence and fibrosis. 
Dysregulation of NF-κβ is responsible for initiating the trans-differentiation of hepatic stellate cells 
into hepatic myofibroblasts. These hepatic myofibroblasts are responsible for extracellular matrix 
production, and their increased presence results in an increase in liver fibrosis [20]. NF-κβ 
upregulation has also been correlated with an increase in the apoptotic cytokine tumor necrosis 
factor alpha (TNF-α) [21]. NF-κβ directly promotes expression of NADPH oxidase, which is 
designed to generate superoxide as a defense mechanism against pathogens and for cell signaling. 
Overexpression of this enzyme, however, causes dangerous levels of superoxide to accumulate, 
resulting in TNF-α excretion and cell senescence [22]. This increased senescence results in fibrosis 
of the liver and a decrease in catabolic enzyme efficiency, which hinders the ability of aged livers 
to process drugs and endogenous compounds. Decreased cell count and enzyme efficiency leads 
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to lower organ function which can cause waste products to accumulate in aged livers, leading to 
failure and further dysfunction [17]. Clinically, this effect is apparent through hepatic volume and 
blood flow in aged individuals, which are both reduced. In 2002, a study using medical 
documentation found that, because of this reduction, metabolic activity was blunted enough to 
warrant recommendation of a starting dose of hepatically cleared drugs that is 30-40% smaller 
than average doses given to patients under the age of 65 [23].  
Similarly, heart disease can arise from age-related oxidative stress. Superoxide anion and 
H2O2 are mediators of vascular smooth muscle cell growth and apoptosis. Increased levels of these 
ROS, similar to what is seen in hepatocytes, can act as a signal to induce the SASP in these cells 
[2]. In cardiomyocytes, high levels of mitochondria are present, which reliably produce ATP to 
ensure the proper function of this crucial organ. In aged individuals, increases occur in superoxide 
and H2O2 concentrations. In the aged heart, mitochondria produce significantly higher levels of 
ROS, which is able to damage mitochondrial DNA. This damage begins a cycle of increased 
mitochondrial ROS production [24]. Increased production leads to the upregulation of 
transcription factors including NF-kβ, resulting in senescence and apoptosis of cardiac myocytes 
through TNF-α. In the heart, this results in reduced cardiac volume, ventricular hypertrophy, and 
fibrosis, putting more strain on remaining cardiomyocytes to keep a steady cardiac output [25]. 
With advanced age, this lack of robust activity may lead to decreased tissue perfusion and 
widespread cell death. To study cardiac health, rodent models have been employed extensively 
and have shown a high level of biological similarity to human cardiac tissue. Commonly, aged 
hearts experience hypertrophy due to hypertension, but NF-κβ has been implicated in a rat model 
of ischemic heart disease. While this necrosis factor is responsible for TNF-α upregulation, it has 
also been shown to upregulate atrial natriuretic factor (ANF). ANF is largely responsible for 
10 
hypertrophic induction due to hypertension, but ROS induced NF-κβ production is positively 
correlated with the upregulation of ANF. As a result, reduced cardiac volume, ventricular 
hypertrophy, and fibrosis are directly correlated to mtDNA damage due to ROS exposure over 
time [26].  
In the renal system, release of ROS from aged mitochondria can lead to  fibrosis and kidney 
dysfunction. ROS release induces production of cytokines including p53 and p16, which regulate 
cell cycle and apoptotic activity. In a 2014 study, high levels of p16 were found in patients with 
age-related renal fibrosis due to mtDNA damage [27]. As is the case in other tissues, this DNA 
damage causes more ROS to leak from the mitochondria’s ETC, causing cellular damage and 
apoptosis (Figure 3). Here, NF-κβ is shown to play another important role in this aging tissue. A 
study using a p16 deletion model in mice recently clarified the relationship between this cytokine 
Figure 3. Age-related apoptosis of renal cells causes interstitial fibrosis, tubular atrophy 
(IF/TA), and glomerulosclerosis (GS). Cellular senescence due to oxidative stress reduces the 
regenerative capacity and function of renal filtration [1]. 
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and NF-κβ. In p16 knockout mice, age-related renal dysfunction (increased glomerular filtration 
pressure and fibrosis) was improved via NF-κβ signal reduction [28]. This not only increases our 
understanding of oxidative kidney dysfunction, but also increases understanding of the role of NF-
κβ in relation to cytokines in other tissues. Importantly, renal and cardiac oxidation are intertwined. 
Cardiac hypertension and hypertrophy are responsible for a decrease in renal perfusion, and 
therefore decreased glomerular filtration rate [29]. Together, oxidative damage to these organs can 
be quite dangerous and even fatal to an aged individual.  
3.1.1 Current Findings in Damage Repair 
In the liver, heart, and kidney, mtDNA damage is both responsible for and increased by 
ROS generation and decreased enzyme efficiency. Keeping in mind that catalase and glutathione 
peroxidase act as a natural defense to H2O2 [30], and that superoxide dismutase works to 
enzymatically reduce superoxide anion [11, 12], it is clear that external ROS mediation is 
necessary in the event of antioxidant failure. Non-enzymatic scavengers of ROS do exist and 
include the antioxidants β-carotene, vitamin C, and vitamin E. Over time, however, mitochondrial 
ROS causes protein damage, leading to deficiencies in the processing power of even these 
antioxidants [31].  
Instead, to combat cell damage, xanthine oxidase is becoming a popular druggable target. 
Allopurinol, a drug used in the treatment of gout to reduce uric acid, acts as an inhibitor of xanthine 
oxidase. In rats, this drug was shown to protect the heart against myocardial infarction caused by 
hypertrophy and fibrosis. Inhibition of xanthine oxidase decreased superoxide and peroxide 
presence in myocardial tissue, with decreased rates of myocardial infarction [32]. More recently, 
a xanthine oxidase inhibitor has been shown to have a lower IC50 than allopurinol using in vivo 
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and in vitro studies. This inhibitor, nitro-oleic acid, is a nitrated fatty acid and an irreversible 
inhibitor of xanthine oxidase. Purified xanthine oxidase exposed to either allopurinol or nitro-oleic 
acid showed inhibition of superoxide formation with IC50 of 2.25μM and 0.75μM, respectively 
[33]. 
A relationship also exists between Polynucleotide Phosphorylase (PNPase) inhibitors and 
oxidative stress. PNPase inhibitors block the catalytic activity of xanthine oxidase, preventing 
superoxide and uric acid formation. One potent inhibitor, 8-aminoguanine (8AG), has shown 
promise in relieving oxidative stress in the urinary system of rats. By inhibiting xanthine oxidase, 
8AG disrupts metabolism of inosine to hypoxanthine and guanosine to guanine. Both inosine and 
guanosine display anti-inflammatory properties in tissues, especially in the lower urinary tract 
(LUT). Exposure of the LUT to ROS over time is correlated with urinary incontinence in humans, 
which may be able to be modulated through the dosing of 8AG [34]. 
An important facet of the discussion of hepatic and renal clearance systems is 
polypharmacy. Polypharmacy may play a role in the extent of oxidative damage, especially in the 
geriatric population. A 2007 study showed that adult patients over the age of 65 are taking about 
9 medications on average [35]. Almost 50% of geriatric patients are currently taking one or more 
prescribed drugs that are not necessary [36]. Geriatric polypharmacy with concomitant oxidative 
damage to clearance organs increases serum residence time of medications, placing constant 
oxidative stress on organs. As mentioned previously, increased ROS presence results in decreased 
enzyme efficiency in hepatocytes, which causes metabolic waste products to accumulate 
[17].Careful prescription of medication to elderly patients, as well as patient and physician 




During the aging process, our cells begin to accumulate highly potent oxidative species 
known as ROS. These species (peroxide, superoxide) are commonly produced by aged 
mitochondria containing damaged mitochondrial DNA. These organelles are capable of leaking 
ROS from their ETC causing damage to antioxidant enzymes and the dysregulation of senescence. 
Additionally, enzymes including xanthine oxidase, NADPH oxidase, and P450 produce ROS 
during necessary metabolism and ATP production, further contributing to the ROS pool in cells. 
Apoptosis markers including NF-κβ and TNF-α are upregulated upon an increased presence of 
ROS, causing increased cell senescence and cell cycle dysregulation in organs such as the liver, 
heart, and kidneys. These organs are often implicated in age-related disease and death, due to ROS 
exposure, which can further increase ROS production and SASP likelihood. Endogenous enzymes 
respond to ROS, but can have reduced function in aged individuals. To combat these challenges, 
compounds such as 8-aminoguanine and nitro-oleic acid are being studied to reduce oxidative 
damage on organs. It is worth noting that polypharmacy plays a role in increasing oxidative 
exposure to the elderly. Through careful prescription, patient education, and research surrounding 
age-related oxidative stress, improvements have and continue to be made in human longevity and 
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